4
MARKET OVERVIEW
Regulatory shifts spark innovation in drug testing, with emerging economies offering lucrative growth prospects.
53
4.2.1.1
GROWING CONSUMPTION OF ILLICIT DRUGS AND ALCOHOL
4.2.1.2
ENFORCEMENT OF STRINGENT LAWS MANDATING DRUG AND ALCOHOL TESTING
4.2.1.3
INCREASING NUMBER OF REGULATORY APPROVALS FOR DRUG SCREENING PRODUCTS & SERVICES
4.2.2.1
BAN ON ALCOHOL CONSUMPTION IN ISLAMIC COUNTRIES
4.2.2.2
PROHIBITION ON WORKPLACE DRUG TESTING
4.2.3.1
POPULARITY OF ORAL FLUID TESTING
4.2.3.2
INTRODUCTION OF FINGERPRINT-BASED DRUG TESTING IN WORKPLACES
4.2.3.3
HIGH GROWTH OPPORTUNITIES IN EMERGING ECONOMIES
4.2.4.1
ACCURACY AND SPECIFICITY CONCERNS IN BREATHALYZERS
4.2.4.2
FALSE POSITIVE AND NEGATIVE RESULTS IN DRUG SCREENING
4.3
UNMET NEEDS & WHITE SPACES
4.4
INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5
INDUSTRY TRENDS
Navigate evolving healthcare IT trends to capitalize on emerging market opportunities and competitive dynamics.
63
5.1
PORTER’S FIVE FORCES ANALYSIS
5.1.1
BARGAINING POWER OF SUPPLIERS
5.1.2
BARGAINING POWER OF BUYERS
5.1.3
THREAT OF SUBSTITUTES
5.1.4
THREAT OF NEW ENTRANTS
5.1.5
INTENSITY OF COMPETITIVE RIVALRY
5.2
MACROECONOMIC INDICATORS
5.2.2
GDP TRENDS & FORECAST
5.2.3
TRENDS IN GLOBAL HEALTHCARE IT INDUSTRY
5.5.1
INDICATIVE PRICING OF DRUG SCREENING PRODUCTS & SERVICES, BY TYPE (2024)
5.5.2
INDICATIVE PRICING OF DRUG SCREENING PRODUCTS & SERVICES, BY REGION (2024)
5.6
KEY CONFERENCES & EVENTS, 2026–2027
5.7
TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.8
INVESTMENT & FUNDING SCENARIO
5.10
IMPACT OF 2025 US TARIFFS ON DRUG SCREENING MARKET
5.10.3
PRICE IMPACT ANALYSIS
5.10.4
IMPACT ON COUNTRY/REGION
5.10.5
IMPACT ON END-USE INDUSTRIES
5.10.5.1
DRUG TESTING LABORATORIES
5.10.5.3
CRIMINAL JUSTICE SYSTEMS & LAW ENFORCEMENT AGENCIES
5.10.5.5
DRUG TREATMENT CENTERS
5.10.5.6
INDIVIDUAL USERS
5.10.5.7
PAIN MANAGEMENT CENTERS
5.10.5.8
SCHOOLS & COLLEGES
6
STRATEGIC DISRUPTIONS THROUGH TECHNOLOGY, PATENTS, AND DIGITAL & AI ADOPTION
Harness AI and emerging tech for transformative drug screening and predictive monitoring advancements.
82
6.1
KEY EMERGING TECHNOLOGIES
6.1.1
LC-MS/MS & GC-MS-BASED CONFIRMATORY TESTING TECHNOLOGIES
6.1.2
AI-DRIVEN RESULT INTERPRETATION & QUALITY ASSURANCE TECHNOLOGIES
6.1.3
LABORATORY AUTOMATION & ROBOTICS TECHNOLOGIES
6.2
COMPLEMENTARY TECHNOLOGIES
6.2.1
MOBILE HEALTH (MHEALTH) & REMOTE COLLECTION TECHNOLOGIES
6.2.2
ANALYTICS & POPULATION-LEVEL DRUG USE SURVEILLANCE TOOLS
6.3
ADJACENT TECHNOLOGIES
6.3.1
FORENSIC CASE MANAGEMENT SYSTEMS
6.3.2
WORKFORCE BACKGROUND SCREENING/VERIFICATION SYSTEMS
6.4
TECHNOLOGY/PRODUCT ROADMAP
6.5.1
PATENT PUBLICATION TRENDS FOR DRUG SCREENING MARKET
6.5.2
INSIGHTS: JURISDICTION & TOP APPLICANT ANALYSIS
6.6.1
AI-ENABLED INTELLIGENT SCREENING AND RESULT INTERPRETATION
6.6.2
CONTINUOUS AND PREDICTIVE DRUG MONITORING APPLICATIONS
6.6.3
DECENTRALIZED, AT-HOME, AND POINT-OF-CARE SCREENING EXPANSION
6.6.4
INTEGRATED COMPLIANCE, FORENSIC, AND PUBLIC HEALTH INTELLIGENCE PLATFORMS
6.6.5
PERSONALIZED AND THERAPEUTIC DRUG SCREENING APPLICATIONS
6.7
IMPACT OF AI/GEN AI ON DRUG SCREENING MARKET
6.7.2
MARKET POTENTIAL OF AI/GEN AI IN DRUG SCREENING MARKET
6.7.3
CASE STUDIES RELATED TO AI/GEN AI IMPLEMENTATION
6.7.3.1
AI-DRIVEN TRANSFORMATION OF PRECLINICAL TOXICOLOGY SCREENING AT PATHAI
6.7.4
IMPACT OF AI/GEN AI ON INTERCONNECTED & ADJACENT ECOSYSTEMS
6.7.4.1
LABORATORY & TOXICOLOGY OPERATIONS
6.7.4.2
LABORATORY INFORMATION SYSTEMS (LIS) & COMPLIANCE INFRASTRUCTURE
6.7.4.3
CLINICAL CARE, WORKPLACE SAFETY, AND MONITORING PROGRAMS
6.7.5
USER READINESS AND IMPACT ASSESSMENT
6.7.5.1.1
USER A: CLINICAL, REFERENCE, AND TOXICOLOGY LABORATORIES
6.7.5.1.2
USER B: HEALTHCARE PROVIDERS, EMPLOYERS, AND FORENSIC AGENCIES
6.7.5.2
IMPACT ASSESSMENT
6.7.5.2.1
USER A: CLINICAL, REFERENCE, AND TOXICOLOGY LABORATORIES
6.7.5.2.2
USER B: HEALTHCARE PROVIDERS, EMPLOYERS, AND FORENSIC AGENCIES
7
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
Unlock key buyer insights and unmet needs driving market profitability and decision-making dynamics.
98
7.2
DECISION-MAKING PROCESS
7.3
BUYER STAKEHOLDERS & BUYING EVALUATION CRITERIA
7.3.1
KEY STAKEHOLDERS IN BUYING PROCESS
7.4
ADOPTION BARRIERS & INTERNAL CHALLENGES
7.5
UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
7.5.2
END-USER EXPECTATIONS
8
REGULATORY LANDSCAPE
Navigate complex global regulations with region-specific insights and compliance frameworks.
105
8.1
REGIONAL REGULATIONS & COMPLIANCE
8.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
8.1.2
REGULATORY FRAMEWORK
8.1.2.5
MIDDLE EAST & AFRICA
9
DRUG SCREENING MARKET, BY OFFERING
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 35 Data Tables
113
9.2.1
WORKFORCE DECENTRALIZATION, PANEL COMPLEXITY, AND LITIGATION-READY TESTING TO DRIVE SUSTAINED MARKET GROWTH
9.2.2
LABORATORY TESTING SERVICES
9.2.2.1
ABILITY TO ENSURE ANALYTICAL RIGOR AND COMPLIANCE WITH REGULATORY STANDARDS TO DRIVE DEMAND
9.2.3
ON-SITE TESTING SERVICES
9.2.3.1
ABILITY TO DELIVER RAPID, POINT-OF-CARE SCREENING SOLUTIONS TO DRIVE MARKET GROWTH
9.3.1
ANALYTICAL INSTRUMENTS MARKET, BY TYPE
9.3.1.1.1
FUEL-CELL BREATHALYZERS
9.3.1.1.2
SEMICONDUCTOR BREATHALYZERS
9.3.1.1.3
OTHER BREATHALYZERS
9.3.1.2
IMMUNOASSAY ANALYZERS
9.3.1.2.1
GROWING ADOPTION OF HIGH-THROUGHPUT IMMUNOASSAY PLATFORMS TO POWER MODERN TOXICOLOGY
9.3.1.3
CHROMATOGRAPHY INSTRUMENTS
9.3.1.3.1
ADVANTAGES SUCH AS PRECISE, HIGH-SENSITIVITY ANALYSIS IN FORENSIC, CLINICAL, AND REGULATORY LABORATORIES TO FUEL GROWTH
9.3.2
ANALYTICAL INSTRUMENTS MARKET, BY MODALITY
9.3.2.1
HANDHELD BREATHALYZERS
9.3.2.1.1
CRITICAL ROLE IN DELIVERING FAST, ACCURATE, AND PORTABLE ALCOHOL SCREENING TO SUPPORT MARKET GROWTH
9.3.2.2
BENCHTOP BREATHALYZERS
9.3.2.2.1
GROWING USE OF BENCHTOP BREATHALYZERS FOR DRUG DETECTION ANALYSIS TO DRIVE GROWTH
9.3.3
RAPID TESTING DEVICES
9.3.3.1
URINE TESTING DEVICES
9.3.3.1.1
DRUG TESTING CUPS
9.3.3.1.3
DRUG TESTING CASSETTES
9.3.3.2
ORAL FLUID TESTING DEVICES
9.3.3.2.1
RAPID, NON-INVASIVE DETECTION OF RECENT DRUG USE ACROSS WORKPLACE, CLINICAL, AND LAW ENFORCEMENT SETTINGS TO FUEL GROWTH
9.3.4.1.1
RAPID, COST-EFFECTIVE, AND HIGH-THROUGHPUT SCREENING ACROSS DRUG TESTING APPLICATIONS TO DRIVE MARKET
9.3.4.2
SAMPLE COLLECTION DEVICES
9.3.4.2.1
RELIABLE, TAMPER-RESISTANT, AND VERSATILE DRUG TESTING ACROSS SETTINGS TO SUPPORT GROWTH
9.3.4.3
CALIBRATORS & CONTROLS
9.3.4.3.1
ABILITY TO VERIFY ACCURACY, PRECISION, AND RELIABILITY OF SCREENING AND CONFIRMATORY TEST RESULTS TO DRIVE GROWTH
9.3.4.4
OTHER CONSUMABLES
10
DRUG SCREENING MARKET, BY SAMPLE TYPE
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 11 Data Tables
142
10.2.1
RECENT ADVANCES TO STRENGTHEN ACCURACY AND RELIABILITY IN URINE DRUG TESTING
10.3.1
BREATH ALCOHOL TESTS TO REGISTER WIDE USAGE IN WORKPLACE TESTING AND LAW ENFORCEMENT APPLICATIONS
10.4.1
NON-INVASIVE SAMPLE COLLECTION AND LOW CHANCE OF ADULTERATION TO SUPPORT USAGE OF ORAL FLUID SAMPLES
10.5.1
ABILITY OF HAIR SAMPLES TO PROVIDE INSIGHTS INTO LONG-TERM DRUG USE TO BOOST MARKET
11
DRUG SCREENING MARKET, BY DRUG TYPE
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 13 Data Tables
150
11.2.1
GROWING CANNABIS USE AND REGULATORY COMPLEXITY TO DRIVE SUSTAINED DEMAND FOR DRUG SCREENING SOLUTIONS
11.3.1
REGULATORY ENFORCEMENT AND TECHNOLOGY INNOVATION TO STRENGTHEN ALCOHOL SCREENING ADOPTION
11.4.1
SHIFT TOWARD RAPID, DEFENSIBLE DETECTION TO POSITION COCAINE AS PRIORITY DRUG IN MODERN SCREENING PANELS
11.5.1
EXPANDED OPIOID PANELS AND ADVANCED CONFIRMATORY TECHNOLOGIES TO REINFORCE OPIOID SCREENING AS HIGH PRIORITY
11.6
AMPHETAMINES & METHAMPHETAMINES
11.6.1
ADVANCED ANALYTICS AND DIFFERENTIATION TESTING TO REDEFINE AMPHETAMINE & METHAMPHETAMINE DETECTION
12
DRUG SCREENING MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 20 Data Tables
161
12.2
DRUG TESTING LABORATORIES
12.2.1
ADVANCED ANALYTICS, AUTOMATION, AND EXPANDING FORENSIC AND CLINICAL DEMAND TO DRIVE MARKET GROWTH
12.3.1
RISING NUMBER OF DRUG ABUSE CASES TO INCREASE WORKPLACE TESTING
12.4
CRIMINAL JUSTICE SYSTEMS & LAW ENFORCEMENT AGENCIES
12.4.1
HIGH SUBSTANCE-USE PREVALENCE AND DUI RISKS TO DRIVE MANDATORY DRUG & ALCOHOL TESTING
12.5.1
RISING EMERGENCY ADMISSIONS, OPIOID OVERDOSES, AND PATIENT SAFETY MANDATES TO DRIVE STRONG DEMAND
12.6
DRUG TREATMENT CENTERS
12.6.1
RISING ADOPTION OF MEDICATION-ASSISTED TREATMENT, RELAPSE MONITORING, AND FENTANYL DETECTION TO DRIVE DEMAND
12.7.1
GROWING SELF-MONITORING, HOME TESTING, AND RECOVERY ACCOUNTABILITY TO EXPANDING INDIVIDUAL USE OF SCREENING
12.8
PAIN MANAGEMENT CENTERS
12.8.1
OPIOID PRESCRIBING OVERSIGHT AND PATIENT SAFETY MANDATES TO DRIVE INCREASED DRUG SCREENING
12.9.1
MODERN TESTING AND AWARENESS PROGRAMS TO STRENGTHEN DRUG ABUSE PREVENTION IN SCHOOLS & COLLEGES
13
DRUG SCREENING MARKET, BY REGION
Comprehensive coverage of 8 Regions with country-level deep-dive of 17 Countries | 348 Data Tables.
175
13.2.1
MACROECONOMIC OUTLOOK FOR NORTH AMERICA
13.2.2.1
REGULATORY ENFORCEMENT AND SUBSTANCE USE PREVALENCE DRIVE DRUG SCREENING MARKET IN US
13.2.3.1
PUBLIC HEALTH SURVEILLANCE, CONSUMPTION TRENDS, AND ENFORCEMENT & TECHNOLOGICAL ADVANCEMENTS TO DRIVE MARKET
13.3.1
MACROECONOMIC OUTLOOK FOR EUROPE
13.3.2.1
STRENGTHENING DRUG SCREENING ADOPTION THROUGH PUBLIC HEALTH POLICY AND TECHNOLOGICAL MODERNIZATION TO SUPPORT MARKET GROWTH
13.3.3.1
REGULATORY ENFORCEMENT, TRANSPORT SAFETY, AND FORENSIC MODERNIZATION TO SHAPE DRUG SCREENING MARKET
13.3.4.1
COMMUNITY-EMBEDDED TESTING, CRIMINAL JUSTICE DEMAND, AND REAL-TIME DRUG SURVEILLANCE TO SHAPE UK DRUG SCREENING MARKET
13.3.5.1
STRENGTHENING DRUG SCREENING MARKET THROUGH ROADSIDE ENFORCEMENT AND ANALYTICAL INNOVATION & INSTITUTIONAL CAPACITY
13.3.6.1
EXPANDING DRUG SCREENING ADOPTION THROUGH ROAD SAFETY PROGRAMS TO DRIVE MARKET GROWTH
13.4.1
MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
13.4.2.1
SYNTHETIC DRUG CONTROL AND PHARMACEUTICAL INNOVATION TO DRIVE DRUG SCREENING MARKET GROWTH
13.4.3.1
JAPAN’S AGING POPULATION AND ADVANCED DIGITAL INFRASTRUCTURE TO DRIVE RAPID ADOPTION
13.4.4.1
ALCOHOL DOMINANCE, OPIOID MISUSE, AND INDIA’S ROLE AS GLOBAL PHARMACEUTICAL HUB TO DRIVE DRUG SCREENING MARKET GROWTH
13.4.5.1
HARM-REDUCTION POLICY, WORKPLACE SAFETY REGULATION, AND ROADSIDE TESTING TO DRIVE DRUG SCREENING MARKET
13.4.6.1
ZERO-TOLERANCE DRUG POLICY, MANDATORY MILITARY SERVICE, AND FORENSIC-GRADE TESTING TO SHAPE DRUG SCREENING MARKET
13.4.7
REST OF ASIA PACIFIC
13.5.1
MACROECONOMIC OUTLOOK FOR LATIN AMERICA
13.5.2.1
BRAZIL’S DRUG SCREENING MARKET TO EXPAND AMID ROAD SAFETY MANDATES, SUBSTANCE-USE BURDEN, AND REGULATORY ENFORCEMENT
13.5.3.1
MEXICO’S DRUG SCREENING MARKET SHAPED BY METHAMPHETAMINE PREVALENCE, CROSS-BORDER LABOR DYNAMICS, AND PUBLIC SAFETY ENFORCEMENT
13.5.4
REST OF LATIN AMERICA
13.6
MIDDLE EAST & AFRICA
13.6.1
MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
13.6.2.1.1
PUBLIC SAFETY, DIAGNOSTIC MODERNIZATION, AND EVOLVING CONSUMPTION PATTERNS TO BOOST MARKET
13.6.2.2.1
INTEGRATED SAFETY ENFORCEMENT, WORKPLACE TESTING, AND DIAGNOSTIC MODERNIZATION TO EXPAND MARKET IN UAE
13.6.2.3
REST OF GCC COUNTRIES
13.6.3.1
RISING SUBSTANCE USE, WORKPLACE RISK MANAGEMENT, AND ADVANCED SCREENING CAPABILITIES TO FUEL MARKET GROWTH
13.6.4
REST OF MIDDLE EAST & AFRICA
14
COMPETITIVE LANDSCAPE
Discover top strategies and financial standings of dominant and emerging players in drug screening.
335
14.2
KEY PLAYER STRATEGIES/RIGHT TO WIN
14.2.1
OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN DRUG SCREENING MARKET
14.3
REVENUE ANALYSIS, 2020–2024
14.4
MARKET SHARE ANALYSIS, 2024
14.6
COMPANY VALUATION & FINANCIAL METRICS
14.7
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
14.7.5
COMPANY FOOTPRINT: KEY PLAYERS, 2024
14.7.5.1
COMPANY FOOTPRINT
14.7.5.2
REGION FOOTPRINT
14.7.5.3
OFFERING FOOTPRINT
14.7.5.4
SAMPLE TYPE FOOTPRINT
14.7.5.5
DRUG TYPE FOOTPRINT
14.7.5.6
END-USER FOOTPRINT
14.8
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
14.8.1
PROGRESSIVE COMPANIES
14.8.2
RESPONSIVE COMPANIES
14.8.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
14.8.5.1
DETAILED LIST OF KEY STARTUPS/SMES
14.8.5.2
COMPETITIVE BENCHMARKING OF STARTUPS/SMES
14.9
COMPETITIVE SCENARIO
14.9.1
PRODUCT LAUNCHES & ENHANCEMENTS
14.9.3
OTHER DEVELOPMENTS
15
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
358
15.1.1.1
BUSINESS OVERVIEW
15.1.1.2
PRODUCTS & SERVICES OFFERED
15.1.1.3
RECENT DEVELOPMENTS
15.1.1.4.2
STRATEGIC CHOICES
15.1.1.4.3
WEAKNESSES & COMPETITIVE THREATS
15.1.2
QUEST DIAGNOSTICS INCORPORATED
15.1.4
ORASURE TECHNOLOGIES INC.
15.1.5
ALFA SCIENTIFIC DESIGNS INC.
15.1.6
THERMO FISHER SCIENTIFIC INC.
15.1.7
DRÄGERWERK AG & CO. KGAA
15.1.8
LIFELOC TECHNOLOGIES, INC.
15.1.10
OMEGA LABORATORIES, INC.
15.1.11
PREMIER BIOTECH, INC.
15.1.12
PSYCHEMEDICS CORPORATION
15.1.13
F. HOFFMANN-LA ROCHE LTD.
15.1.14
SHIMADZU CORPORATION
15.1.15
SIEMENS HEALTHINEERS AG
15.1.16
BIO-RAD LABORATORIES, INC.
15.2.1
CAREHEALTH AMERICA CORP.
15.2.2
ACCUSOURCEHR, INC.
15.2.3
CORDANT HEALTH SOLUTIONS
15.2.5
ACM GLOBAL LABORATORIES
15.2.7
CLINICAL REFERENCE LABORATORY, INC.
16
RESEARCH METHODOLOGY
433
16.1.1
SECONDARY RESEARCH
16.1.1.1
KEY DATA FROM SECONDARY SOURCES
16.1.2.2
KEY DATA FROM PRIMARY SOURCES
16.1.2.3
BREAKDOWN OF PRIMARIES
16.1.2.4
INSIGHTS FROM PRIMARY EXPERTS
16.2
RESEARCH METHODOLOGY DESIGN
16.3
MARKET SIZE ESTIMATION
16.4
MARKET BREAKDOWN & DATA TRIANGULATION
16.5
MARKET SHARE ESTIMATION
16.7
RESEARCH LIMITATIONS
16.7.1
METHODOLOGY-RELATED LIMITATIONS
17.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
17.3
CUSTOMIZATION OPTIONS
TABLE 1
EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
TABLE 2
KEY PRODUCT & SERVICE LAUNCHES FOR DRUG & ALCOHOL TESTING, 2022–2025
TABLE 3
REGULATORY AUTHORITIES FOR DRUG & ALCOHOL TESTING PRODUCTS & SERVICES
TABLE 4
DRUG SCREENING MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 5
DRUG SCREENING MARKET: ROLE IN ECOSYSTEM
TABLE 6
INDICATIVE PRICING OF DRUG SCREENING PRODUCTS & SERVICES, BY TYPE, 2024 (USD)
TABLE 7
INDICATIVE PRICING OF DRUG SCREENING PRODUCTS & SERVICES, BY REGION, 2024 (USD)
TABLE 8
DRUG SCREENING MARKET: KEY CONFERENCES & EVENTS, 2026–2027
TABLE 9
CASE 1: COMPREHENSIVE ORAL FLUID DUID TESTING PROGRAM
TABLE 10
CASE 2: HIGH-THROUGHPUT GC-MS DRUG SCREENING IN FORENSIC URINE TESTING
TABLE 11
CASE 3: ORAL FLUID DRUG TESTING IMPLEMENTATION IN A DRUG COURT PROGRAM
TABLE 12
US-ADJUSTED RECIPROCAL TARIFF RATES
TABLE 13
JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR DRUG SCREENING MARKET
TABLE 14
DRUG SCREENING MARKET: LIST OF PATENTS/PATENT APPLICATIONS
TABLE 15
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF TOP THREE END USERS (%)
TABLE 16
KEY BUYING CRITERIA FOR TOP THREE END USERS
TABLE 17
UNMET NEEDS IN DRUG SCREENING MARKET
TABLE 18
END-USER EXPECTATIONS IN DRUG SCREENING MARKET
TABLE 19
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 20
EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 21
ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 22
LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 23
MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 24
REGULATORY SCENARIO OF NORTH AMERICA
TABLE 25
REGULATORY SCENARIO OF EUROPE
TABLE 26
REGULATORY SCENARIO OF ASIA PACIFIC
TABLE 27
REGULATORY SCENARIO OF LATIN AMERICA
TABLE 28
REGULATORY SCENARIO OF MIDDLE EAST & AFRICA
TABLE 29
DRUG SCREENING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 30
DRUG SCREENING SERVICES MARKET: MAJOR PLAYERS & OFFERINGS
TABLE 31
DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 32
DRUG SCREENING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 33
DRUG SCREENING MARKET FOR LABORATORY TESTING SERVICES, BY REGION, 2023–2030 (USD MILLION)
TABLE 34
DRUG SCREENING MARKET FOR ON-SITE TESTING SERVICES, BY REGION, 2023–2030 (USD MILLION)
TABLE 35
DRUG SCREENING PRODUCTS MARKET: MAJOR PLAYERS & OFFERINGS
TABLE 36
DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 37
DRUG SCREENING PRODUCTS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 38
DRUG SCREENING MARKET FOR ANALYTICAL INSTRUMENTS, BY REGION, 2023–2030 (USD MILLION)
TABLE 39
DRUG SCREENING MARKET FOR ANALYTICAL INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 40
DRUG SCREENING MARKET FOR BREATHALYZERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 41
DRUG SCREENING MARKET FOR BREATHALYZERS, BY REGION, 2023–2030 (USD MILLION)
TABLE 42
DRUG SCREENING MARKET FOR FUEL-CELL BREATHALYZERS, BY REGION, 2023–2030 (USD MILLION)
TABLE 43
DRUG SCREENING MARKET FOR SEMICONDUCTOR BREATHALYZERS, BY REGION, 2023–2030 (USD MILLION)
TABLE 44
DRUG SCREENING MARKET FOR OTHER BREATHALYZERS, BY REGION, 2023–2030 (USD MILLION)
TABLE 45
DRUG SCREENING MARKET FOR IMMUNOASSAY ANALYZERS, BY REGION, 2023–2030 (USD MILLION)
TABLE 46
DRUG SCREENING MARKET FOR CHROMATOGRAPHY INSTRUMENTS, BY REGION, 2023–2030 (USD MILLION)
TABLE 47
DRUG SCREENING MARKET FOR ANALYTICAL INSTRUMENTS, BY MODALITY, 2023–2030 (USD MILLION)
TABLE 48
DRUG SCREENING MARKET FOR HANDHELD BREATHALYZERS, BY REGION, 2023–2030 (USD MILLION)
TABLE 49
DRUG SCREENING MARKET FOR BENCHTOP BREATHALYZERS, BY REGION, 2023–2030 (USD MILLION)
TABLE 50
DRUG SCREENING MARKET FOR RAPID TESTING DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 51
DRUG SCREENING MARKET FOR RAPID TESTING DEVICES, BY REGION, 2023–2030 (USD MILLION)
TABLE 52
BLOOD SCREENING MARKET FOR URINE TESTING DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 53
DRUG SCREENING MARKET FOR URINE TESTING DEVICES, BY REGION, 2023–2030 (USD MILLION)
TABLE 54
DRUG SCREENING MARKET FOR DRUG TESTING CUPS, BY REGION, 2023–2030 (USD MILLION)
TABLE 55
DRUG SCREENING MARKET FOR DIP CARDS, BY REGION, 2023–2030 (USD MILLION)
TABLE 56
DRUG SCREENING MARKET FOR DRUG TESTING CASSETTES, BY REGION, 2023–2030 (USD MILLION)
TABLE 57
DRUG SCREENING MARKET FOR ORAL FLUID TESTING DEVICES, BY REGION, 2023–2030 (USD MILLION)
TABLE 58
DRUG SCREENING MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 59
DRUG SCREENING MARKET FOR CONSUMABLES, BY REGION, 2023–2030 (USD MILLION)
TABLE 60
DRUG SCREENING MARKET FOR ASSAY KITS, BY REGION, 2023–2030 (USD MILLION)
TABLE 61
DRUG SCREENING MARKET FOR SAMPLE COLLECTION DEVICES, BY REGION, 2023–2030 (USD MILLION)
TABLE 62
DRUG SCREENING MARKET FOR CALIBRATORS & CONTROLS, BY REGION, 2023–2030 (USD MILLION)
TABLE 63
DRUG SCREENING MARKET FOR OTHER CONSUMABLES, BY REGION, 2023–2030 (USD MILLION)
TABLE 64
DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION)
TABLE 65
DRUG SCREENING MARKET FOR URINE SAMPLES: MAJOR PLAYERS & OFFERINGS
TABLE 66
DRUG SCREENING MARKET FOR URINE SAMPLES, BY REGION, 2023–2030 (USD MILLION)
TABLE 67
DRUG SCREENING MARKET FOR BREATH SAMPLES: MAJOR PLAYERS & OFFERINGS
TABLE 68
DRUG SCREENING MARKET FOR BREATH SAMPLES, BY REGION, 2023–2030 (USD MILLION)
TABLE 69
DRUG SCREENING MARKET FOR ORAL FLUID SAMPLES: MAJOR PLAYERS & OFFERINGS
TABLE 70
DRUG SCREENING MARKET FOR ORAL FLUID SAMPLES, BY REGION, 2023–2030 (USD MILLION)
TABLE 71
DRUG SCREENING MARKET FOR HAIR SAMPLES: MAJOR PLAYERS & OFFERINGS
TABLE 72
DRUG SCREENING MARKET FOR HAIR SAMPLES, BY REGION, 2023–2030 (USD MILLION)
TABLE 73
DRUG SCREENING MARKET FOR OTHER SAMPLES: MAJOR PLAYERS & OFFERINGS
TABLE 74
DRUG SCREENING MARKET FOR OTHER SAMPLES, BY REGION, 2023–2030 (USD MILLION)
TABLE 75
DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION)
TABLE 76
DRUG SCREENING MARKET FOR CANNABIS: MAJOR PLAYERS & OFFERINGS
TABLE 77
DRUG SCREENING MARKET FOR CANNABIS, BY REGION, 2023–2030 (USD MILLION)
TABLE 78
DRUG SCREENING MARKET FOR ALCOHOL: MAJOR PLAYERS & OFFERINGS
TABLE 79
DRUG SCREENING MARKET FOR ALCOHOL, BY REGION, 2023–2030 (USD MILLION)
TABLE 80
DRUG SCREENING MARKET FOR COCAINE: MAJOR PLAYERS & OFFERINGS
TABLE 81
DRUG SCREENING MARKET FOR COCAINE, BY REGION, 2023–2030 (USD MILLION)
TABLE 82
DRUG SCREENING MARKET FOR OPIOIDS: MAJOR PLAYERS & OFFERINGS
TABLE 83
DRUG SCREENING MARKET FOR OPIDS, BY REGION, 2023–2030 (USD MILLION)
TABLE 84
DRUG SCREENING MARKET FOR AMPHETAMINES & METHAMPHETAMINES: MAJOR PLAYERS & OFFERINGS
TABLE 85
DRUG SCREENING MARKET FOR AMPHETAMINES & METHAMPHETAMINES, BY REGION, 2023–2030 (USD MILLION)
TABLE 86
DRUG SCREENING MARKET FOR OTHER DRUGS: MAJOR PLAYERS & OFFERINGS
TABLE 87
DRUG SCREENING MARKET FOR OTHER DRUGS, BY REGION, 2023–2030 (USD MILLION)
TABLE 88
DRUG SCREENING MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 89
DRUG SCREENING MARKET FOR DRUG TESTING LABORATORIES: MAJOR PLAYERS & OFFERINGS
TABLE 90
DRUG SCREENING MARKET FOR DRUG TESTING LABORATORIES, BY REGION, 2023–2030 (USD MILLION)
TABLE 91
DRUG SCREENING MARKET FOR WORKPLACES: MAJOR PLAYERS & OFFERINGS
TABLE 92
DRUG SCREENING MARKET FOR WORKPLACES, BY REGION, 2023–2030 (USD MILLION)
TABLE 93
US: DRUG SCREENING MARKET FOR WORKPLACES, BY TYPE, 2019–2026 (USD MILLION)
TABLE 94
DRUG SCREENING MARKET FOR CRIMINAL JUSTICE SYSTEMS & LAW ENFORCEMENT AGENCIES: MAJOR PLAYERS & OFFERINGS
TABLE 95
DRUG SCREENING MARKET FOR CRIMINAL JUSTICE SYSTEMS & LAW ENFORCEMENT AGENCIES, BY REGION, 2023–2030 (USD MILLION)
TABLE 96
DRUG SCREENING MARKET FOR HOSPITALS: MAJOR PLAYERS & OFFERINGS
TABLE 97
DRUG SCREENING MARKET FOR HOSPITALS, BY REGION, 2023–2030 (USD MILLION)
TABLE 98
DRUG SCREENING MARKET FOR DRUG TREATMENT CENTERS: MAJOR PLAYERS & OFFERINGS
TABLE 99
DRUG SCREENING MARKET FOR DRUG TREATMENT CENTERS, BY REGION, 2023–2030 (USD MILLION)
TABLE 100
DRUG SCREENING MARKET FOR INDIVIDUAL USERS: MAJOR PLAYERS & OFFERINGS
TABLE 101
DRUG SCREENING MARKET FOR INDIVIDUAL USERS, BY REGION, 2023–2030 (USD MILLION)
TABLE 102
DRUG SCREENING MARKET FOR PAIN MANAGEMENT CENTERS: MAJOR PLAYERS & OFFERINGS
TABLE 103
DRUG SCREENING MARKET FOR PAIN MANAGEMENT CENTERS, BY REGION, 2023–2030 (USD MILLION)
TABLE 104
DRUG SCREENING MARKET FOR SCHOOLS & COLLEGES: MAJOR PLAYERS & OFFERINGS
TABLE 105
DRUG SCREENING MARKET FOR SCHOOLS & COLLEGES, BY REGION, 2023–2030 (USD MILLION)
TABLE 106
DRUG SCREENING MARKET FOR OTHER END USERS: MAJOR PLAYERS & OFFERINGS
TABLE 107
DRUG SCREENING MARKET FOR OTHER END USERS, BY REGION, 2023–2030 (USD MILLION)
TABLE 108
DRUG SCREENING MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 109
NORTH AMERICA: MACROECONOMIC INDICATORS
TABLE 110
NORTH AMERICA: DRUG SCREENING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 111
NORTH AMERICA: DRUG SCREENING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 112
NORTH AMERICA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 113
NORTH AMERICA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 114
NORTH AMERICA: DRUG SCREENING MARKET FOR ANALYTICAL INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 115
NORTH AMERICA: DRUG SCREENING MARKET FOR BREATHALYZERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 116
NORTH AMERICA: DRUG SCREENING MARKET FOR ANALYTICAL INSTRUMENTS, BY MODALITY, 2023–2030 (USD MILLION)
TABLE 117
NORTH AMERICA: DRUG SCREENING MARKET FOR RAPID TESTING DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 118
NORTH AMERICA: DRUG SCREENING MARKET FOR URINE TESTING DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 119
NORTH AMERICA: DRUG SCREENING MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 120
NORTH AMERICA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION)
TABLE 121
NORTH AMERICA: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION)
TABLE 122
NORTH AMERICA: DRUG SCREENING MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 123
US: DRUG SCREENING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 124
US: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 125
US: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 126
US: DRUG SCREENING MARKET FOR ANALYTICAL INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 127
US: DRUG SCREENING MARKET FOR BREATHALYZERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 128
US: DRUG SCREENING MARKET FOR ANALYTICAL INSTRUMENTS, BY MODALITY, 2023–2030 (USD MILLION)
TABLE 129
US: DRUG SCREENING MARKET FOR RAPID TESTING DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 130
US: DRUG SCREENING MARKET FOR URINE TESTING DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 131
US: DRUG SCREENING MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 132
US: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION)
TABLE 133
US: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION)
TABLE 134
US: DRUG SCREENING MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 135
CANADA: DRUG SCREENING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 136
CANADA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 137
CANADA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 138
CANADA: DRUG SCREENING MARKET FOR ANALYTICAL INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 139
CANADA: DRUG SCREENING MARKET FOR BREATHALYZERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 140
CANADA: DRUG SCREENING MARKET FOR ANALYTICAL INSTRUMENTS, BY MODALITY, 2023–2030 (USD MILLION)
TABLE 141
CANADA: DRUG SCREENING MARKET FOR RAPID TESTING DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 142
CANADA: DRUG SCREENING MARKET FOR URINE TESTING DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 143
CANADA: DRUG SCREENING MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 144
CANADA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION)
TABLE 145
CANADA: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION)
TABLE 146
CANADA: DRUG SCREENING MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 147
EUROPE: MACROECONOMIC INDICATORS
TABLE 148
EUROPE: DRUG SCREENING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 149
EUROPE: DRUG SCREENING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 150
EUROPE: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 151
EUROPE: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 152
EUROPE: DRUG SCREENING MARKET FOR ANALYTICAL INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 153
EUROPE: DRUG SCREENING MARKET FOR BREATHALYZERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 154
EUROPE: DRUG SCREENING MARKET FOR ANALYTICAL INSTRUMENTS, BY MODALITY, 2023–2030 (USD MILLION)
TABLE 155
EUROPE: DRUG SCREENING MARKET FOR RAPID TESTING DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 156
EUROPE: DRUG SCREENING MARKET FOR URINE TESTING DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 157
EUROPE: DRUG SCREENING MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 158
EUROPE: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION)
TABLE 159
EUROPE: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION)
TABLE 160
EUROPE: DRUG SCREENING MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 161
GERMANY: DRUG SCREENING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 162
GERMANY: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 163
GERMANY: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 164
GERMANY: DRUG SCREENING MARKET FOR ANALYTICAL INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 165
GERMANY: DRUG SCREENING MARKET FOR BREATHALYZERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 166
GERMANY: DRUG SCREENING MARKET FOR ANALYTICAL INSTRUMENTS, BY MODALITY, 2023–2030 (USD MILLION)
TABLE 167
GERMANY: DRUG SCREENING MARKET FOR RAPID TESTING DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 168
GERMANY: DRUG SCREENING MARKET FOR URINE TESTING DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 169
GERMANY: DRUG SCREENING MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 170
GERMANY: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION)
TABLE 171
GERMANY: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION)
TABLE 172
GERMANY: DRUG SCREENING MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 173
FRANCE: DRUG SCREENING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 174
FRANCE: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 175
FRANCE: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 176
FRANCE: DRUG SCREENING MARKET FOR ANALYTICAL INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 177
FRANCE: DRUG SCREENING MARKET FOR BREATHALYZERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 178
FRANCE: DRUG SCREENING MARKET FOR ANALYTICAL INSTRUMENTS, BY MODALITY, 2023–2030 (USD MILLION)
TABLE 179
FRANCE: DRUG SCREENING MARKET FOR RAPID TESTING DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 180
FRANCE: DRUG SCREENING MARKET FOR URINE TESTING DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 181
FRANCE: DRUG SCREENING MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 182
FRANCE: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION)
TABLE 183
FRANCE: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION)
TABLE 184
FRANCE: DRUG SCREENING MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 185
UK: DRUG SCREENING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 186
UK: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 187
UK: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 188
UK: DRUG SCREENING MARKET FOR ANALYTICAL INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 189
UK: DRUG SCREENING MARKET FOR BREATHALYZERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 190
UK: DRUG SCREENING MARKET FOR ANALYTICAL INSTRUMENTS, BY MODALITY, 2023–2030 (USD MILLION)
TABLE 191
UK: DRUG SCREENING MARKET FOR RAPID TESTING DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 192
UK: DRUG SCREENING MARKET FOR URINE TESTING DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 193
UK: DRUG SCREENING MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 194
UK: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION)
TABLE 195
UK: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION)
TABLE 196
UK: DRUG SCREENING MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 197
ITALY: DRUG SCREENING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 198
ITALY: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 199
ITALY: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 200
ITALY: DRUG SCREENING MARKET FOR ANALYTICAL INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 201
ITALY: DRUG SCREENING MARKET FOR BREATHALYZERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 202
ITALY: DRUG SCREENING MARKET FOR ANALYTICAL INSTRUMENTS, BY MODALITY, 2023–2030 (USD MILLION)
TABLE 203
ITALY: DRUG SCREENING MARKET FOR RAPID TESTING DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 204
ITALY: DRUG SCREENING MARKET FOR URINE TESTING DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 205
ITALY: DRUG SCREENING MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 206
ITALY: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION)
TABLE 207
ITALY: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION)
TABLE 208
ITALY: DRUG SCREENING MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 209
SPAIN: DRUG SCREENING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 210
SPAIN: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 211
SPAIN: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 212
SPAIN: DRUG SCREENING MARKET FOR ANALYTICAL INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 213
SPAIN: DRUG SCREENING MARKET FOR BREATHALYZERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 214
SPAIN: DRUG SCREENING MARKET FOR ANALYTICAL INSTRUMENTS, BY MODALITY, 2023–2030 (USD MILLION)
TABLE 215
SPAIN: DRUG SCREENING MARKET FOR RAPID TESTING DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 216
SPAIN: DRUG SCREENING MARKET FOR URINE TESTING DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 217
SPAIN: DRUG SCREENING MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 218
SPAIN: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION)
TABLE 219
SPAIN: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION)
TABLE 220
SPAIN: DRUG SCREENING MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 221
REST OF EUROPE: DRUG SCREENING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 222
REST OF EUROPE: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 223
REST OF EUROPE: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 224
REST OF EUROPE: DRUG SCREENING MARKET FOR ANALYTICAL INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 225
REST OF EUROPE: DRUG SCREENING MARKET FOR BREATHALYZERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 226
REST OF EUROPE: DRUG SCREENING MARKET FOR ANALYTICAL INSTRUMENTS, BY MODALITY, 2023–2030 (USD MILLION)
TABLE 227
REST OF EUROPE: DRUG SCREENING MARKET FOR RAPID TESTING DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 228
REST OF EUROPE: DRUG SCREENING MARKET FOR URINE TESTING DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 229
REST OF EUROPE: DRUG SCREENING MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 230
REST OF EUROPE: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION)
TABLE 231
REST OF EUROPE: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION)
TABLE 232
REST OF EUROPE: DRUG SCREENING MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 233
ASIA PACIFIC: MACROECONOMIC INDICATORS
TABLE 234
ASIA PACIFIC: DRUG SCREENING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 235
ASIA PACIFIC: DRUG SCREENING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 236
ASIA PACIFIC: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 237
ASIA PACIFIC: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 238
ASIA PACIFIC: DRUG SCREENING MARKET FOR ANALYTICAL INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 239
ASIA PACIFIC: DRUG SCREENING MARKET FOR BREATHALYZERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 240
ASIA PACIFIC: DRUG SCREENING MARKET FOR ANALYTICAL INSTRUMENTS, BY MODALITY, 2023–2030 (USD MILLION)
TABLE 241
ASIA PACIFIC: DRUG SCREENING MARKET FOR RAPID TESTING DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 242
ASIA PACIFIC: DRUG SCREENING MARKET FOR URINE TESTING DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 243
ASIA PACIFIC: DRUG SCREENING MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 244
ASIA PACIFIC: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION)
TABLE 245
ASIA PACIFIC: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION)
TABLE 246
ASIA PACIFIC: DRUG SCREENING MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 247
CHINA: DRUG SCREENING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 248
CHINA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 249
CHINA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 250
CHINA: DRUG SCREENING MARKET FOR ANALYTICAL INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 251
CHINA: DRUG SCREENING MARKET FOR BREATHALYZERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 252
CHINA: DRUG SCREENING MARKET FOR ANALYTICAL INSTRUMENTS, BY MODALITY, 2023–2030 (USD MILLION)
TABLE 253
CHINA: DRUG SCREENING MARKET FOR RAPID TESTING DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 254
CHINA: DRUG SCREENING MARKET FOR URINE TESTING DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 255
CHINA: DRUG SCREENING MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 256
CHINA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION)
TABLE 257
CHINA: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION)
TABLE 258
CHINA: DRUG SCREENING MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 259
JAPAN: DRUG SCREENING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 260
JAPAN: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 261
JAPAN: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 262
JAPAN: DRUG SCREENING MARKET FOR ANALYTICAL INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 263
JAPAN: DRUG SCREENING MARKET FOR BREATHALYZERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 264
JAPAN: DRUG SCREENING MARKET FOR ANALYTICAL INSTRUMENTS, BY MODALITY, 2023–2030 (USD MILLION)
TABLE 265
JAPAN: DRUG SCREENING MARKET FOR RAPID TESTING DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 266
JAPAN: DRUG SCREENING MARKET FOR URINE TESTING DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 267
JAPAN: DRUG SCREENING MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 268
JAPAN: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION)
TABLE 269
JAPAN: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION)
TABLE 270
JAPAN: DRUG SCREENING MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 271
INDIA: DRUG SCREENING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 272
INDIA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 273
INDIA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 274
INDIA: DRUG SCREENING MARKET FOR ANALYTICAL INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 275
INDIA: DRUG SCREENING MARKET FOR BREATHALYZERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 276
INDIA: DRUG SCREENING MARKET FOR ANALYTICAL INSTRUMENTS, BY MODALITY, 2023–2030 (USD MILLION)
TABLE 277
INDIA: DRUG SCREENING MARKET FOR RAPID TESTING DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 278
INDIA: DRUG SCREENING MARKET FOR URINE TESTING DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 279
INDIA: DRUG SCREENING MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 280
INDIA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION)
TABLE 281
INDIA: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION)
TABLE 282
INDIA: DRUG SCREENING MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 283
AUSTRALIA: DRUG SCREENING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 284
AUSTRALIA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 285
AUSTRALIA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 286
AUSTRALIA: DRUG SCREENING MARKET FOR ANALYTICAL INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 287
AUSTRALIA: DRUG SCREENING MARKET FOR BREATHALYZERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 288
AUSTRALIA: DRUG SCREENING MARKET FOR ANALYTICAL INSTRUMENTS, BY MODALITY, 2023–2030 (USD MILLION)
TABLE 289
AUSTRALIA: DRUG SCREENING MARKET FOR RAPID TESTING DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 290
AUSTRALIA: DRUG SCREENING MARKET FOR URINE TESTING DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 291
AUSTRALIA: DRUG SCREENING MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 292
AUSTRALIA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION)
TABLE 293
AUSTRALIA: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION)
TABLE 294
AUSTRALIA: DRUG SCREENING MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 295
SOUTH KOREA: DRUG SCREENING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 296
SOUTH KOREA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 297
SOUTH KOREA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 298
SOUTH KOREA: DRUG SCREENING MARKET FOR ANALYTICAL INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 299
SOUTH KOREA: DRUG SCREENING MARKET FOR BREATHALYZERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 300
SOUTH KOREA: DRUG SCREENING MARKET FOR ANALYTICAL INSTRUMENTS, BY MODALITY, 2023–2030 (USD MILLION)
TABLE 301
SOUTH KOREA: DRUG SCREENING MARKET FOR RAPID TESTING DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 302
SOUTH KOREA: DRUG SCREENING MARKET FOR URINE TESTING DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 303
SOUTH KOREA: DRUG SCREENING MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 304
SOUTH KOREA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION)
TABLE 305
SOUTH KOREA: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION)
TABLE 306
SOUTH KOREA: DRUG SCREENING MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 307
REST OF ASIA PACIFIC: DRUG SCREENING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 308
REST OF ASIA PACIFIC: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 309
REST OF ASIA PACIFIC: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 310
REST OF ASIA PACIFIC: DRUG SCREENING MARKET FOR ANALYTICAL INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 311
REST OF ASIA PACIFIC: DRUG SCREENING MARKET FOR BREATHALYZERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 312
REST OF ASIA PACIFIC: DRUG SCREENING MARKET FOR ANALYTICAL INSTRUMENTS, BY MODALITY, 2023–2030 (USD MILLION)
TABLE 313
REST OF ASIA PACIFIC: DRUG SCREENING MARKET FOR RAPID TESTING DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 314
REST OF ASIA PACIFIC: DRUG SCREENING MARKET FOR URINE TESTING DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 315
REST OF ASIA PACIFIC: DRUG SCREENING MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 316
REST OF ASIA PACIFIC: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION)
TABLE 317
REST OF ASIA PACIFIC: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION)
TABLE 318
REST OF ASIA PACIFIC: DRUG SCREENING MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 319
LATIN AMERICA: MACROECONOMIC INDICATORS
TABLE 320
LATIN AMERICA: DRUG SCREENING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 321
LATIN AMERICA: DRUG SCREENING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 322
LATIN AMERICA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 323
LATIN AMERICA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 324
LATIN AMERICA: DRUG SCREENING MARKET FOR ANALYTICAL INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 325
LATIN AMERICA: DRUG SCREENING MARKET FOR BREATHALYZERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 326
LATIN AMERICA: DRUG SCREENING MARKET FOR ANALYTICAL INSTRUMENTS, BY MODALITY, 2023–2030 (USD MILLION)
TABLE 327
LATIN AMERICA: DRUG SCREENING MARKET FOR RAPID TESTING DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 328
LATIN AMERICA: DRUG SCREENING MARKET FOR URINE TESTING DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 329
LATIN AMERICA: DRUG SCREENING MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 330
LATIN AMERICA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION)
TABLE 331
LATIN AMERICA: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION)
TABLE 332
LATIN AMERICA: DRUG SCREENING MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 333
BRAZIL: DRUG SCREENING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 334
BRAZIL: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 335
BRAZIL: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 336
BRAZIL: DRUG SCREENING MARKET FOR ANALYTICAL INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 337
BRAZIL: DRUG SCREENING MARKET FOR BREATHALYZERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 338
BRAZIL: DRUG SCREENING MARKET FOR ANALYTICAL INSTRUMENTS, BY MODALITY, 2023–2030 (USD MILLION)
TABLE 339
BRAZIL: DRUG SCREENING MARKET FOR RAPID TESTING DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 340
BRAZIL: DRUG SCREENING MARKET FOR URINE TESTING DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 341
BRAZIL: DRUG SCREENING MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 342
BRAZIL: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION)
TABLE 343
BRAZIL: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION)
TABLE 344
BRAZIL: DRUG SCREENING MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 345
MEXICO: DRUG SCREENING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 346
MEXICO: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 347
MEXICO: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 348
MEXICO: DRUG SCREENING MARKET FOR ANALYTICAL INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 349
MEXICO: DRUG SCREENING MARKET FOR BREATHALYZERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 350
MEXICO: DRUG SCREENING MARKET FOR ANALYTICAL INSTRUMENTS, BY MODALITY, 2023–2030 (USD MILLION)
TABLE 351
MEXICO: DRUG SCREENING MARKET FOR RAPID TESTING DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 352
MEXICO: DRUG SCREENING MARKET FOR URINE TESTING DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 353
MEXICO: DRUG SCREENING MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 354
MEXICO: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION)
TABLE 355
MEXICO: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION)
TABLE 356
MEXICO: DRUG SCREENING MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 357
REST OF LATIN AMERICA: DRUG SCREENING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 358
REST OF LATIN AMERICA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 359
REST OF LATIN AMERICA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 360
REST OF LATIN AMERICA: DRUG SCREENING MARKET FOR ANALYTICAL INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 361
REST OF LATIN AMERICA: DRUG SCREENING MARKET FOR BREATHALYZERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 362
REST OF LATIN AMERICA: DRUG SCREENING MARKET FOR ANALYTICAL INSTRUMENTS, BY MODALITY, 2023–2030 (USD MILLION)
TABLE 363
REST OF LATIN AMERICA: DRUG SCREENING MARKET FOR RAPID TESTING DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 364
REST OF LATIN AMERICA: DRUG SCREENING MARKET FOR URINE TESTING DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 365
REST OF LATIN AMERICA: DRUG SCREENING MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 366
REST OF LATIN AMERICA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION)
TABLE 367
REST OF LATIN AMERICA: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION)
TABLE 368
REST OF LATIN AMERICA: DRUG SCREENING MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 369
MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS
TABLE 370
MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 371
MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 372
MIDDLE EAST & AFRICA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 373
MIDDLE EAST & AFRICA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 374
MIDDLE EAST & AFRICA: DRUG SCREENING MARKET FOR ANALYTICAL INSTRUMENTS, BY TYPE,2023–2030 (USD MILLION)
TABLE 375
MIDDLE EAST & AFRICA: DRUG SCREENING MARKET FOR BREATHALYZERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 376
MIDDLE EAST & AFRICA: DRUG SCREENING MARKET FOR ANALYTICAL INSTRUMENTS, BY MODALITY, 2023–2030 (USD MILLION)
TABLE 377
MIDDLE EAST & AFRICA: DRUG SCREENING MARKET FOR RAPID TESTING DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 378
MIDDLE EAST & AFRICA: DRUG SCREENING MARKET FOR URINE TESTING DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 379
MIDDLE EAST & AFRICA: DRUG SCREENING MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 380
MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION)
TABLE 381
MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION)
TABLE 382
MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 383
GCC COUNTRIES: DRUG SCREENING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 384
GCC COUNTRIES: DRUG SCREENING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 385
GCC COUNTRIES: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 386
GCC COUNTRIES: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 387
GCC COUNTRIES: DRUG SCREENING MARKET FOR ANALYTICAL INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 388
GCC COUNTRIES: DRUG SCREENING MARKET FOR BREATHALYZERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 389
GCC COUNTRIES: DRUG SCREENING MARKET FOR ANALYTICAL INSTRUMENTS, BY MODALITY, 2023–2030 (USD MILLION)
TABLE 390
GCC COUNTRIES: DRUG SCREENING MARKET FOR RAPID TESTING DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 391
GCC COUNTRIES: DRUG SCREENING MARKET FOR URINE TESTING DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 392
GCC COUNTRIES: DRUG SCREENING MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 393
GCC COUNTRIES: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION)
TABLE 394
GCC COUNTRIES: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION)
TABLE 395
GCC COUNTRIES: DRUG SCREENING MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 396
SAUDI ARABIA: DRUG SCREENING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 397
SAUDI ARABIA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 398
SAUDI ARABIA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 399
SAUDI ARABIA: DRUG SCREENING MARKET FOR ANALYTICAL INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 400
SAUDI ARABIA: DRUG SCREENING MARKET FOR BREATHALYZERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 401
SAUDI ARABIA: DRUG SCREENING MARKET FOR ANALYTICAL INSTRUMENTS, BY MODALITY, 2023–2030 (USD MILLION)
TABLE 402
SAUDI ARABIA: DRUG SCREENING MARKET FOR RAPID TESTING DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 403
SAUDI ARABIA: DRUG SCREENING MARKET FOR URINE TESTING DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 404
SAUDI ARABIA: DRUG SCREENING MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 405
SAUDI ARABIA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION)
TABLE 406
SAUDI ARABIA: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION)
TABLE 407
SAUDI ARABIA: DRUG SCREENING MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 408
UAE: DRUG SCREENING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 409
UAE: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 410
UAE: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 411
UAE: DRUG SCREENING MARKET FOR ANALYTICAL INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 412
UAE: DRUG SCREENING MARKET FOR BREATHALYZERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 413
UAE: DRUG SCREENING MARKET FOR ANALYTICAL INSTRUMENTS, BY MODALITY, 2023–2030 (USD MILLION)
TABLE 414
UAE: DRUG SCREENING MARKET FOR RAPID TESTING DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 415
UAE: DRUG SCREENING MARKET FOR URINE TESTING DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 416
UAE: DRUG SCREENING MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 417
UAE: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION)
TABLE 418
UAE: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION)
TABLE 419
UAE: DRUG SCREENING MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 420
REST OF GCC COUNTRIES: DRUG SCREENING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 421
REST OF GCC COUNTRIES: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 422
REST OF GCC COUNTRIES: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 423
REST OF GCC COUNTRIES: DRUG SCREENING MARKET FOR ANALYTICAL INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 424
REST OF GCC COUNTRIES: DRUG SCREENING MARKET FOR BREATHALYZERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 425
REST OF GCC COUNTRIES: DRUG SCREENING MARKET FOR ANALYTICAL INSTRUMENTS, BY MODALITY, 2023–2030 (USD MILLION)
TABLE 426
REST OF GCC COUNTRIES: DRUG SCREENING MARKET FOR RAPID TESTING DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 427
REST OF GCC COUNTRIES: DRUG SCREENING MARKET FOR URINE TESTING DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 428
REST OF GCC COUNTRIES: DRUG SCREENING MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 429
REST OF GCC COUNTRIES: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION)
TABLE 430
REST OF GCC COUNTRIES: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION)
TABLE 431
REST OF GCC COUNTRIES: DRUG SCREENING MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 432
SOUTH AFRICA: DRUG SCREENING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 433
SOUTH AFRICA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 434
SOUTH AFRICA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 435
SOUTH AFRICA: DRUG SCREENING MARKET FOR ANALYTICAL INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 436
SOUTH AFRICA: DRUG SCREENING MARKET FOR BREATHALYZERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 437
SOUTH AFRICA: DRUG SCREENING MARKET FOR ANALYTICAL INSTRUMENTS, BY MODALITY, 2023–2030 (USD MILLION)
TABLE 438
SOUTH AFRICA: DRUG SCREENING MARKET FOR RAPID TESTING DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 439
SOUTH AFRICA: DRUG SCREENING MARKET FOR URINE TESTING DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 440
SOUTH AFRICA: DRUG SCREENING MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 441
SOUTH AFRICA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION)
TABLE 442
SOUTH AFRICA: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION)
TABLE 443
SOUTH AFRICA: DRUG SCREENING MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 444
REST OF MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 445
REST OF MIDDLE EAST & AFRICA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 446
REST OF MIDDLE EAST & AFRICA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 447
REST OF MIDDLE EAST & AFRICA: DRUG SCREENING MARKET FOR ANALYTICAL INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 448
REST OF MIDDLE EAST & AFRICA: DRUG SCREENING MARKET FOR BREATHALYZERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 449
REST OF MIDDLE EAST & AFRICA: DRUG SCREENING MARKET FOR ANALYTICAL INSTRUMENTS, BY MODALITY, 2023–2030 (USD MILLION)
TABLE 450
REST OF MIDDLE EAST & AFRICA: DRUG SCREENING MARKET FOR RAPID TESTING DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 451
REST OF MIDDLE EAST & AFRICA: DRUG SCREENING MARKET FOR URINE TESTING DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 452
REST OF MIDDLE EAST & AFRICA: DRUG SCREENING MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 453
REST OF MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION)
TABLE 454
REST OF MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION)
TABLE 455
REST OF MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 456
OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN DRUG SCREENING, JANUARY 2022–DECEMBER 2025
TABLE 457
DRUG SCREENING MARKET: DEGREE OF COMPETITION
TABLE 458
DRUG SCREENING MARKET: REGION FOOTPRINT
TABLE 459
DRUG SCREENING MARKET: OFFERING FOOTPRINT
TABLE 460
DRUG SCREENING MARKET: SAMPLE TYPE FOOTPRINT
TABLE 461
DRUG SCREENING MARKET: DRUG TYPE FOOTPRINT
TABLE 462
DRUG SCREENING MARKET: END-USER FOOTPRINT
TABLE 463
DRUG SCREENING MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
TABLE 464
DRUG SCREENING MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS, BY REGION
TABLE 465
DRUG SCREENING MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS, BY OFFERING
TABLE 466
DRUG SCREENING MARKET: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022– DECEMBER 2025
TABLE 467
DRUG SCREENING MARKET: DEALS, JANUARY 2022–DECEMBER 2025
TABLE 468
DRUG SCREENING MARKET: OTHER DEVELOPMENTS, JANUARY 2022–DECEMBER 2025
TABLE 469
LABCORP: COMPANY OVERVIEW
TABLE 470
LABCORP: PRODUCTS & SERVICES OFFERED
TABLE 471
LABCORP: DEALS, JANUARY 2022–DECEMBER 2025
TABLE 472
QUEST DIAGNOSTICS INCORPORATED: COMPANY OVERVIEW
TABLE 473
QUEST DIAGNOSTICS INCORPORATED: PRODUCTS & SERVICES OFFERED
TABLE 474
QUEST DIAGNOSTICS INCORPORATED: PRODUCT & SERVICE LAUNCHES, JANUARY 2022–DECEMBER 2025
TABLE 475
QUEST DIAGNOSTICS INCORPORATED: DEALS, JANUARY 2022–DECEMBER 2025
TABLE 476
ABBOTT: COMPANY OVERVIEW
TABLE 477
ABBOTT: PRODUCTS & SERVICES OFFERED
TABLE 478
ORASURE TECHNOLOGIES INC.: COMPANY OVERVIEW
TABLE 479
ORASURE TECHNOLOGIES INC.: PRODUCTS & SERVICES OFFERED
TABLE 480
ORASURE TECHNOLOGIES INC.: DEALS, JANUARY 2022–DECEMBER 2025
TABLE 481
ALFA SCIENTIFIC DESIGNS INC.: COMPANY OVERVIEW
TABLE 482
ALFA SCIENTIFIC DESIGNS INC.: PRODUCTS & SERVICES OFFERED
TABLE 483
THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
TABLE 484
THERMO FISHER SCIENTIFIC INC.: PRODUCTS & SERVICES OFFERED
TABLE 485
THERMO FISHER SCIENTIFIC INC.: PRODUCT DEVELOPMENTS, JANUARY 2022–DECEMBER 2025
TABLE 486
THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2022–DECEMBER 2025
TABLE 487
DRÄGERWERK AG & CO. KGAA: COMPANY OVERVIEW
TABLE 488
DRÄGERWERK AG & CO. KGAA: PRODUCTS & SERVICES OFFERED
TABLE 489
DRÄGERWERK AG & CO. KGAA: PRODUCT LAUNCHES, JANUARY 2022–DECEMBER 2025
TABLE 490
LIFELOC TECHNOLOGIES, INC.: COMPANY OVERVIEW
TABLE 491
LIFELOC TECHNOLOGIES, INC.: PRODUCTS & SERVICES OFFERED
TABLE 492
LIFELOC TECHNOLOGIES, INC.: OTHER DEVELOPMENTS, JANUARY 2022–DECEMBER 2025
TABLE 493
MPD INC.: COMPANY OVERVIEW
TABLE 494
MPD INC.: PRODUCTS & SERVICES OFFERED
TABLE 495
OMEGA LABORATORIES, INC.: COMPANY OVERVIEW
TABLE 496
OMEGA LABORATORIES, INC.: PRODUCTS & SERVICES OFFERED
TABLE 497
OMEGA LABORATORIES, INC.: SERVICE LAUNCHES, JANUARY 2022–DECEMBER 2025
TABLE 498
OMEGA LABORATORIES, INC.: DEALS, JANUARY 2022–DECEMBER 2025
TABLE 499
OMEGA LABORATORIES, INC.: OTHER DEVELOPMENTS, JANUARY 2022–DECEMBER 2025
TABLE 500
PREMIER BIOTECH, INC.: COMPANY OVERVIEW
TABLE 501
PREMIER BIOTECH, INC.: PRODUCTS & SERVICES OFFERED
TABLE 502
PREMIER BIOTECH, INC.: DEALS, JANUARY 2022–DECEMBER 2025
TABLE 503
PSYCHEMEDICS CORPORATION: COMPANY OVERVIEW
TABLE 504
PSYCHEMEDICS CORPORATION: PRODUCTS & SERVICES OFFERED
TABLE 505
PSYCHEMEDICS CORPORATION: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022–DECEMBER 2025
TABLE 506
PSYCHEMEDICS CORPORATION: OTHER DEVELOPMENTS, JANUARY 2022–DECEMBER 2025
TABLE 507
F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW
TABLE 508
F. HOFFMANN-LA ROCHE LTD.: PRODUCTS & SERVICES OFFERED
TABLE 509
F. HOFFMANN-LA ROCHE LTD.: DEALS, JANUARY 2022–DECEMBER 2025
TABLE 510
SHIMADZU CORPORATION: COMPANY OVERVIEW
TABLE 511
SHIMADZU CORPORATION: PRODUCTS & SERVICES OFFERED
TABLE 512
SHIMADZU CORPORATION: PRODUCT LAUNCHES, JANUARY 2022–DECEMBER 2025
TABLE 513
SHIMADZU CORPORATION: DEALS, JANUARY 2022–DECEMBER 2025
TABLE 514
SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW
TABLE 515
SIEMENS HEALTHINEERS AG: PRODUCTS & SERVICES OFFERED
TABLE 516
SIEMENS HEALTHINEERS AG: PRODUCT LAUNCHES, JANUARY 2022–DECEMBER 2025
TABLE 517
SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2022–DECEMBER 2025
TABLE 518
BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
TABLE 519
BIO-RAD LABORATORIES, INC.: PRODUCTS & SERVICES OFFERED
TABLE 520
BIO-RAD LABORATORIES, INC.: PRODUCT ENHANCEMENTS, JANUARY 2022–DECEMBER 2025
TABLE 521
BIO-RAD LABORATORIES, INC.: DEALS, JANUARY 2022–DECEMBER 2025
TABLE 522
CAREHEALTH AMERICA CORP.: COMPANY OVERVIEW
TABLE 523
ACCUSOURCEHR, INC.: COMPANY OVERVIEW
TABLE 524
CORDANT HEALTH SOLUTIONS: COMPANY OVERVIEW
TABLE 525
ADVACARE PHARMA: COMPANY OVERVIEW
TABLE 526
ACM GLOBAL LABORATORIES: COMPANY OVERVIEW
TABLE 527
MILLENNIUM HEALTH: COMPANY OVERVIEW
TABLE 528
CLINICAL REFERENCE LABORATORY, INC.: COMPANY OVERVIEW
TABLE 529
INTOXIMETERS: COMPANY OVERVIEW
TABLE 530
INTOXALOCK: COMPANY OVERVIEW
TABLE 531
RISK ASSESSMENT: DRUG SCREENING MARKET
FIGURE 1
DRUG SCREENING MARKET SEGMENTATION & REGIONAL SCOPE
FIGURE 3
GLOBAL DRUG SCREENING MARKET, 2023–2030
FIGURE 4
MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN DRUG SCREENING MARKET, 2022–2025
FIGURE 5
DISRUPTIONS INFLUENCING GROWTH OF DRUG SCREENING MARKET
FIGURE 6
HIGH-GROWTH SEGMENTS IN DRUG SCREENING MARKET, 2025–2030
FIGURE 7
ASIA PACIFIC TO REGISTER HIGHEST CAGR IN DRUG SCREENING MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD
FIGURE 8
EXPANDING WORKPLACE SAFETY MANDATES AND RISING SUBSTANCE ABUSE AWARENESS TO DRIVE MARKET GROWTH
FIGURE 9
DRUG SCREENING PRODUCTS MARKET IN NORTH AMERICA ACCOUNTED FOR LARGEST SHARE IN 2024
FIGURE 10
INDIA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
FIGURE 11
GROWTH RATES OF EMERGING ECONOMIES TO BE HIGHER THAN THOSE OF DEVELOPED ECONOMIES DURING FORECAST PERIOD
FIGURE 12
DRUG SCREENING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 13
DRUG SCREENING MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 14
DRUG SCREENING MARKET: VALUE CHAIN ANALYSIS (2024)
FIGURE 15
DRUG SCREENING MARKET: ECOSYSTEM ANALYSIS
FIGURE 16
TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 18
PATENT PUBLICATION TRENDS IN DRUG CREENING MARKET, 2015–2025
FIGURE 19
JURISDICTION & TOP APPLICANT ANALYSIS FOR DRUG SCREENING MARKET
FIGURE 20
TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR DRUG SCREENING MARKET (JANUARY 2015 TO DECEMBER 2025)
FIGURE 21
MARKET POTENTIAL OF AI/GEN AI ON DRUG SCREENING ACROSS INDUSTRIES
FIGURE 22
IMPACT OF AI/GEN AI ON INTERCONNECTED & ADJACENT ECOSYSTEMS
FIGURE 23
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS
FIGURE 24
KEY BUYING CRITERIA FOR TOP THREE END USERS
FIGURE 25
NORTH AMERICA: DRUG SCREENING MARKET SNAPSHOT
FIGURE 26
ASIA PACIFIC: DRUG SCREENING MARKET SNAPSHOT
FIGURE 27
REVENUE ANALYSIS OF KEY PLAYERS IN DRUG SCREENING MARKET, 2020–2024
FIGURE 28
MARKET SHARE ANALYSIS OF KEY PLAYERS IN DRUG SCREENING MARKET, 2024
FIGURE 29
DRUG SCREENING MARKET: BRAND COMPARATIVE ANALYSIS
FIGURE 30
EV/EBITDA OF KEY VENDORS
FIGURE 31
YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 32
DRUG SCREENING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
FIGURE 33
DRUG SCREENING MARKET: COMPANY FOOTPRINT
FIGURE 34
DRUG SCREENING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
FIGURE 35
LABCORP: COMPANY SNAPSHOT (2024)
FIGURE 36
QUEST DIAGNOSTICS INCORPORATED: COMPANY SNAPSHOT (2024)
FIGURE 37
ABBOTT: COMPANY SNAPSHOT (2024)
FIGURE 38
ORASURE TECHNOLOGIES INC.: COMPANY SNAPSHOT (2024)
FIGURE 39
THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2024)
FIGURE 40
DRÄGERWERK AG & CO. KGAA: COMPANY SNAPSHOT (2024)
FIGURE 41
LIFELOC TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2024)
FIGURE 42
PSYCHEMEDICS CORPORATION: COMPANY SNAPSHOT (2024)
FIGURE 43
F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2024)
FIGURE 44
SHIMADZU CORPORATION: COMPANY SNAPSHOT (2024)
FIGURE 45
SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2025)
FIGURE 46
BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2024)
FIGURE 47
RESEARCH DESIGN
FIGURE 48
BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 49
RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
FIGURE 50
BOTTOM-UP APPROACH
FIGURE 51
TOP-DOWN APPROACH
FIGURE 52
CAGR PROJECTIONS FROM ANALYSIS OF MARKET DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN DRUG SCREENING INDUSTRY
FIGURE 53
CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 54
DATA TRIANGULATION METHODOLOGY
Chase
Apr, 2026
We are defining our market strategy. Does the report provide actionable insights for market entry and competitive positioning?.
Ryder
Apr, 2026
How is microbiome data being integrated into drug screening and biomedical research for better therapeutic outcomes?.
Finn
Apr, 2026
How are AI and biomarker research driving advancements in drug discovery and precision medicine applications?.
Eric
Apr, 2026
How is medicinal chemistry supporting advancements in drug screening and molecular-level healthcare research?.
Ryan
Apr, 2026
Could you provide detailed insights on oral fluid drug testing market trends, segmentation, and adoption across Europe, especially in law enforcement and security applications?.
Caspian
Apr, 2026
With workplace drug testing becoming more regulated, how do you see organizations balancing compliance costs with operational efficiency, especially for large-scale screening programs?.
Elio
Apr, 2026
From a buyer’s perspective, what are the biggest barriers to adopting advanced drug and alcohol screening technologies in emerging markets?.
Luca
Apr, 2026
How do you assess the ROI of implementing random drug screening programs versus pre-employment testing alone?.
Avery
Apr, 2026
There’s growing concern around data privacy and accuracy in drug testing. How can companies build trust while scaling these solutions?.
Theo
Apr, 2026
Looking ahead, what emerging opportunities do you see shaping the future of the drug and alcohol screening market?.